Atria Investments Inc Trims Holdings in The Clorox Company (NYSE:CLX)

Atria Investments Inc cut its position in shares of The Clorox Company (NYSE:CLX) by 2.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,578 shares of the company’s stock after selling 401 shares during the quarter. Atria Investments Inc’s holdings in Clorox were worth $3,026,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of CLX. Insight Folios Inc raised its holdings in Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after acquiring an additional 63 shares during the last quarter. Fiduciary Group LLC increased its stake in Clorox by 0.4% in the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock valued at $2,600,000 after purchasing an additional 72 shares during the last quarter. GHP Investment Advisors Inc. increased its stake in Clorox by 2.0% in the second quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock valued at $496,000 after purchasing an additional 72 shares during the last quarter. SPC Financial Inc. lifted its position in Clorox by 2.2% during the second quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after buying an additional 75 shares during the period. Finally, Massmutual Trust Co. FSB ADV boosted its stake in Clorox by 17.2% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $83,000 after buying an additional 75 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

CLX has been the topic of several recent analyst reports. Evercore ISI cut their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. JPMorgan Chase & Co. increased their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Deutsche Bank Aktiengesellschaft increased their target price on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Finally, DA Davidson upped their price target on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $155.00.

Clorox Stock Performance

Clorox stock opened at $165.37 on Thursday. The firm has a market capitalization of $20.47 billion, a PE ratio of 57.62, a price-to-earnings-growth ratio of 3.04 and a beta of 0.41. The Clorox Company has a one year low of $127.60 and a one year high of $169.09. The stock’s 50 day moving average price is $162.35 and its 200 day moving average price is $147.08. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period in the previous year, the company posted $0.49 earnings per share. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. As a group, sell-side analysts expect that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.95%. The ex-dividend date was Wednesday, October 23rd. Clorox’s payout ratio is 170.04%.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.57% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.